產(chǎn)品介紹 品名 Monoclonal Antibody to Human C3a 貨號(hào) A203 規(guī)格 100 μL 同種型 IgG1k 蛋白質(zhì)濃度 > 1.0 mg/mL 純度 ≥ 95% by SDS PAGE 緩沖液 Borate Buffered Saline (pH 8.4 ± 0.2) 儲(chǔ)存 Storage: ≤ 30 Days 2-8?C > 30 Days ≤ –20?C 使用說(shuō)明 For Research Use Only. Not for use in Diagnostic Procedures 產(chǎn)品描述 A murine monoclonal antibody to the human C3a domain of C3. This monoclonal antibody was raised against purified human C3. It is specific for an antigen expressed on the C3a domain of C3 and therefore reactive to C3 and C3a. Quidel's C3a monoclonal antibody has been used in a variety of experimental techniques including EIA and Western Blot. Please contact Quidel Technical Support for details on these or other applications. Because it is not specific for a neo-epitope on C3a, it may not be suitable for all EIA applications 背景 The human complement component, C3, consists of two disulfide-bonded subunits (Alpha – 115,000 kD and Beta – 75,000 kD). The concentration of C3 in serum is approximately 1.25 + 0.52 mg/ml. Under normal conditions, activation of either the Classical, Lectin or Alternative Complement Pathways produces C3 convertase which cleaves C3 into two fragments – C3a, an anaphylatoxin, and C3b. Quidel’s monoclonal antibodies to complement antigens were prepared using standard techniques. They are purified from mouse ascites fluid via Protein A affinity chromatography. Quidel’s Anti-Human C3a monoclonal antibody was raised against highly pure human C3 protein. 應(yīng)用 參考資料 Tamerius, J.D., Pangburn, M., et al. Detection of a neoAntigen on human iC3b and C3d by monoclonal Antibody, J. Immunol. 135:2015, 1985. Tamerius, J.D., Pangburn, M., et al. Selective inhibition of functional sites of cell bound C3b by hybridoma derived antibodies, J. Immunol 128:512, 1982.
產(chǎn)品介紹
Monoclonal Antibody to Human C3a
A203
100 μL
IgG1k
> 1.0 mg/mL
≥ 95% by SDS PAGE
Borate Buffered Saline (pH 8.4 ± 0.2)
Storage: ≤ 30 Days 2-8?C > 30 Days ≤ –20?C
For Research Use Only. Not for use in Diagnostic Procedures
A murine monoclonal antibody to the human C3a domain of C3.
This monoclonal antibody was raised against purified human C3. It is specific for an antigen expressed on the C3a domain of C3 and therefore reactive to C3 and C3a.
Quidel's C3a monoclonal antibody has been used in a variety of experimental techniques including EIA and Western Blot. Please contact Quidel Technical Support for details on these or other applications. Because it is not specific for a neo-epitope on C3a, it may not be suitable for all EIA applications
The human complement component, C3, consists of two disulfide-bonded subunits (Alpha – 115,000 kD and Beta – 75,000 kD). The concentration of C3 in serum is approximately 1.25 + 0.52 mg/ml. Under normal conditions, activation of either the Classical, Lectin or Alternative Complement Pathways produces C3 convertase which cleaves C3 into two fragments – C3a, an anaphylatoxin, and C3b.
Quidel’s monoclonal antibodies to complement antigens were prepared using standard techniques. They are purified from mouse ascites fluid via Protein A affinity chromatography. Quidel’s Anti-Human C3a monoclonal antibody was raised against highly pure human C3 protein.
Tamerius, J.D., Pangburn, M., et al. Detection of a neoAntigen on human iC3b and C3d by monoclonal Antibody, J. Immunol. 135:2015, 1985.
Tamerius, J.D., Pangburn, M., et al. Selective inhibition of functional sites of cell bound C3b by hybridoma derived antibodies, J. Immunol 128:512, 1982.
BIOLEAF熱搜 BIOLEAF試劑盒 BIOLEAF ELISA BIOLEAF試劑 BIOLEAF品牌 BIOLEAF抗體 BIOLEAF耗材 BIOLEAF小儀器
sitemap 細(xì)胞庫(kù)查詢 危險(xiǎn)品圖標(biāo) 本公司網(wǎng)站所展示銷售的產(chǎn)品僅供科研！
滬公網(wǎng)安備 31011202007338號(hào)
